ARTIVION, INC. (AORT)
ARTIVION, INC. (AORT) from its SEC filings: 2025 revenue $441.3 million (+14% vs the year before), net margin 2%, free cash flow $839,000. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $441.3 million |
| Revenue growth | +14% |
| Net income | $9.8 million |
| Net margin | 2.2% |
| Free cash flow | $839,000 |
| Diluted EPS | $0.21 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +11% |
| Cash | $77.3 million |
| Long-term debt | $363.4 million |
| Share count, 1 year | +3% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.